RIGL · Rigel Pharmaceuticals Inc · Investor Relations
$47.15
+0.18 (+0.38%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$900.00M
Shares
18.68M
Volume · Oct 2
186.43K
Avg daily vol (3M)
307.4K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-15 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-09-10 | Cantor Global Healthcare Conference 2026 | Conference |
| 2026-08-13 | August 2026 Corporate Presentation | Presentation |
| 2026-08-04 | Second Quarter 2026 Financial Results | Event |
| 2026-08-04 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-08-04 | August 2026 Corporate Presentation | Presentation |
| 2026-06-16 | June 2026 Corporate Presentation | Presentation |
| 2026-06-03 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-19 | 2026 RBC Capital Markets Global Healthcare Conference | Conference |
| 2026-05-14 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-05-12 | Rigel Pharmaceuticals, Inc. VEPPANU (vepdegestrant) Licensing Agreement Conference Call | Conference |
| 2026-05-05 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-03 | Earnings conference call (announced in 8-K) | Earnings call |
Source: https://www.rigel.com/investors